Jacks Lee serves as Executive at G1 Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Jacks Lee has executed 5 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Sep 18, 2024 involved selling 10,000 shares valued at $0.
Jacks Lee currently holds 10,000 shares of G1 Therapeutics, Inc. (GTHX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jacks Lee has been a net neutral trader of GTHX stock. They have purchased $0 and sold $0 worth of shares.
Jacks Lee's most recent insider trade was on Sep 18, 2024, when they sold 10,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jun 13, 2024 | GTHX | $0 | Award | 10,000 | $N/A | Discretionary |
| Jun 6, 2024 | PCVX | $0 | Award | 1,550 | $N/A | Discretionary |
| Jun 15, 2023 | GTHX | $0 | Award | 10,000 | $N/A | Discretionary |